Finnadvence has achieved another milestone by receiving the ISO 9001 certification. This internationally recognized standard for quality management systems demonstrates the company’s commitment to delivering the highest quality products and services to their customers and ensuring the highest industry standards.
Oulu-based Finnadvance is a biotechnology company that develops highly scalable organ-on-chip platforms, which provide a high-throughput system for pharma and academia. The company has recently launched the product line, AKITA. The AKITA’s platform is designed to recreate various microphysiological conditions. Its proprietary design and surface chemistry allow cell adhesion and growth. As a result, the innovation grants cheaper and more effective drugs for both pharmaceutical companies and patients.
The Finnadvance team has worked tirelessly to meet the rigorous requirements of ISO 9001, which includes a focus on customer satisfaction, continuous improvement, and adherence to industry best practices. This achievement is a testament to their dedication to continuously improving their processes and delivering the highest quality organ-on-chip platform.
Read more about Finnadvance and Akita.